J Islam1,2, D Ashiru-Oredope3, E Budd3, P Howard4,5, A S Walker6, S Hopkins3, M J Llewelyn1,2. 1. Department of Microbiology and Infection, Brighton and Sussex University Hospitals NHS Trust, Brighton BN2 5BE, UK. 2. Department of Global Health and Infection, Brighton and Sussex Medical School, Falmer BN1 9PS, UK. 3. AMR Programme, Public Health England, Wellington House, 133-155 Waterloo Rd, London SE1 8UG, UK. 4. Department of Medicines Management and Pharmacy, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK. 5. Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK. 6. Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Abstract
Background: In 2016/2017, a financially linked antibiotic prescribing quality improvement initiative Commissioning for Quality and Innovation (AMR-CQUIN) was introduced across acute hospitals in England. This aimed for >1% reductions in DDDs/1000 admissions of total antibiotics, piperacillin/tazobactam and carbapenems compared with 2013/2014 and improved review of empirical antibiotic prescriptions. Objectives: To assess perceptions of staff leading antimicrobial stewardship activity regarding the AMR-CQUIN, the investments made by hospitals to achieve it and how these related to achieving reductions in antibiotic use. Methods: We invited antimicrobial stewardship leads at acute hospitals across England to complete a web-based survey. Antibiotic prescribing data were downloaded from the PHE Antimicrobial Resistance Local Indicators resource. Results: Responses were received from 116/155 (75%) acute hospitals. Owing to yearly increases in antibiotic use, most trusts needed to make >5% reductions in antibiotic consumption to achieve the AMR-CQUIN goal of 1% reduction. Additional funding was made available at 23/113 (20%) trusts and, in 18 (78%), this was <10% of the AMR-CQUIN value. Nationally, the annual trend for increased antibiotic use reversed in 2016/2017. In 2014/2015, year-on-year changes were +3.7% (IQR -0.8%, +8.4%), +9.4% (+0.2%, +19.5%) and +5.8% (-6.2%, +18.2%) for total antibiotics, piperacillin/tazobactam and carbapenems, respectively, and +0.1% (-5.4%, +4.0%), -4.8% (-16.9%, +3.2%) and -8.0% (-20.2%, +4.0%) in 2016/2017. Hospitals where staff believed they could reduce antibiotic use were more likely to do so (P < 0.001). Conclusions: Introducing the AMR-CQUIN was associated with a reduction in antibiotic use. For individual hospitals, achieving the AMR-CQUIN was associated with favourable perceptions of staff and not availability of funding.
Background: In 2016/2017, a financially linked antibiotic prescribing quality improvement initiative Commissioning for Quality and Innovation (AMR-CQUIN) was introduced across acute hospitals in England. This aimed for >1% reductions in DDDs/1000 admissions of total antibiotics, piperacillin/tazobactam and carbapenems compared with 2013/2014 and improved review of empirical antibiotic prescriptions. Objectives: To assess perceptions of staff leading antimicrobial stewardship activity regarding the AMR-CQUIN, the investments made by hospitals to achieve it and how these related to achieving reductions in antibiotic use. Methods: We invited antimicrobial stewardship leads at acute hospitals across England to complete a web-based survey. Antibiotic prescribing data were downloaded from the PHE Antimicrobial Resistance Local Indicators resource. Results: Responses were received from 116/155 (75%) acute hospitals. Owing to yearly increases in antibiotic use, most trusts needed to make >5% reductions in antibiotic consumption to achieve the AMR-CQUIN goal of 1% reduction. Additional funding was made available at 23/113 (20%) trusts and, in 18 (78%), this was <10% of the AMR-CQUIN value. Nationally, the annual trend for increased antibiotic use reversed in 2016/2017. In 2014/2015, year-on-year changes were +3.7% (IQR -0.8%, +8.4%), +9.4% (+0.2%, +19.5%) and +5.8% (-6.2%, +18.2%) for total antibiotics, piperacillin/tazobactam and carbapenems, respectively, and +0.1% (-5.4%, +4.0%), -4.8% (-16.9%, +3.2%) and -8.0% (-20.2%, +4.0%) in 2016/2017. Hospitals where staff believed they could reduce antibiotic use were more likely to do so (P < 0.001). Conclusions: Introducing the AMR-CQUIN was associated with a reduction in antibiotic use. For individual hospitals, achieving the AMR-CQUIN was associated with favourable perceptions of staff and not availability of funding.
Authors: Laurence S J Roope; James Buchanan; Liz Morrell; Koen B Pouwels; Katy Sivyer; Fiona Mowbray; Lucy Abel; Elizabeth L A Cross; Lucy Yardley; Tim Peto; A Sarah Walker; Martin J Llewelyn; Sarah Wordsworth Journal: BMC Med Date: 2020-07-30 Impact factor: 8.775
Authors: Ann Sarah Walker; Eric Budgell; Magda Laskawiec-Szkonter; Katy Sivyer; Sarah Wordsworth; Jack Quaddy; Marta Santillo; Adele Krusche; Laurence S J Roope; Nicole Bright; Fiona Mowbray; Nicola Jones; Kieran Hand; Najib Rahman; Melissa Dobson; Emma Hedley; Derrick Crook; Mike Sharland; Chris Roseveare; F D Richard Hobbs; Chris Butler; Louella Vaughan; Susan Hopkins; Lucy Yardley; Timothy E A Peto; Martin J Llewelyn Journal: Trials Date: 2019-07-11 Impact factor: 2.279
Authors: Sion Scott; Michael J Twigg; Allan Clark; Carol Farrow; Helen May; Martyn Patel; Johanna Taylor; David J Wright; Debi Bhattacharya Journal: Age Ageing Date: 2019-12-01 Impact factor: 10.668